UBS O'Connor’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-15,000
Closed -$2.63K – 626
2023
Q3
$2.63K Buy
+15,000
New +$787K ﹤0.01% 549

Other funds holding MORF

UBS O'Connor's MORF Position: Q3 2023 in Review

UBS O'Connor sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2023, closing a stake of 14,635 shares — an estimated $768K sold.

UBS O'Connor first reported a position in MORF in Q1 2022 and held it in 6 quarters. The position peaked at $1.41M in Q1 2022. 134 funds tracked by Wall St. Rank hold MORF as of Q3 2023.

  • UBS O'Connor reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 14,635 Morphic Holding, Inc. Common Stock shares in Q3 2023, an estimated $768K.
  • UBS O'Connor first reported a position in Morphic Holding, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • UBS O'Connor's Morphic Holding, Inc. Common Stock position peaked at $1.41M in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.